MallikaSachdevDhawanMD

Oncology • San Francisco, CA

Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Medical Director, Genentech, gRED

Join to view full profile

Dr. Dhawan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dhawan's full profile

Already have an account?

Office
1825 4th St
San Francisco, CA 94143

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2014 - 2017
Duke University HospitalResidency, Internal Medicine, 2011 - 2014
University of California San Diego School of MedicineClass of 2011
University of California, San DiegoB.S., Bioengineering, Magna Cum Laude, 2002 - 2006

Certifications & Licensure

CA State Medical License 2014 - 2026
NC State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Rosenberg Prostate Cancer Research Fellow 2017
Sean Quinlan Career Development Award 2016
Simon Strauss Foundation Cancer Center Award 2015
Scholarship American Society of Nephrology, 2009
Medical Scholars Program UC San Diego, 2002
Regents Scholarship University of California, 2002
Scholarship Jacobs School of Engineering, 2002
Phi Beta Kappa Honor Society 2002
Phi Beta Kappa 2002
Join now to see all

Clinical Trials

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations Start of enrollment: 2020 Jun 18
Suspended
Phase 1

Publications & Presentations

PubMed

Updated Survival Follow-Up for Phase Ib Trial of the Histone Deacetylase Inhibitor Abexinostat With Pazopanib in Patients With Solid Tumor Malignancies.
Erica S Tsang, Rahul R Aggarwal, Emily K Bergsland, Susan Calabrese, Alexandrine Rozie
JCO Precision Oncology. 2024-11-01
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Petros Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal
Clinical Cancer Research. 2024-10-15
Treatment Patterns and Clinical Outcomes Among Patients With Metastatic Prostate Cancer Harboring Homologous Recombination Repair Mutations.
Priyanka J Bobbili, Jasmina Ivanova, David B Solit, Niharika B Mettu, Shannon J McCall
Clinical Genitourinary Cancer. 2024-06-01

External Links

UCSF profilehttp://profiles.ucsf.edu/mallika.dhawan